Momenta Pharmaceuticals, Inc. (MNTA)

[iwfal]

I certainly wouldn't think her idea is to just create numerous duopolies for each drug which again would be saddled by a patent term. The ink's not dry on any paperwork, either from the FDA or HHS, and I'm pretty sure it'll be looked at.

As I have noted repeatedly - these duopolies are not likely to be long lasting (relative to patent duration). Or even compared to FDA biogeneric FDA approval timelines (e.g. 8 years for aL). So she needn't worry.